Article Text
PDF
Abstract
Introduction/Background Vulvar cancer accounts less than 1% of malignant neoplasms in women and 3–5% of female genital tumors.
Generally, the diagnosis of the disease is given in post-menopausal women aged over 50 years, with 50% being between 70 years and over, in series.
However, this neoplasm can also occur in younger patients, series being described with 12 to 15% cases before 45 years of age. The most frequent histological type is squamous cell carcinoma, responsible for 75 to 90% of cases.
Vulvar cancer can be cured in its early stages with early detection and timely treatment. It is estimated that 30 to 35% of vulvar cancer cases are in stages III and IV (FIGO). Survival being 43% and 13%, respectively.
Methodology Retrospective study, descriptive type.
Results Surgery remains the first treatment option in resectable locally advanced disease.
Primary radiotherapy and neoadjuvant treatment should be secondary options.
Conclusion -Vulvar carcinoma represents 4% of gynecological cancers.
-Locally advanced squamous cell carcinoma of the vulva must be individualized, including different forms of presentation and different treatment modalities.
-The clinical presentation and central tumor size is reality in developing countries and should be considere dan important prognostic factor in order to see therapeutic strategies.
Poster para congreso de estambul. Cancer vulvar localmente avanzado.
Disclosures No existen conflicto de intereses entre el autor ni coautores.